RAC 3.14% $1.48 race oncology ltd

It would probably be good to touch on:To what degree we can...

  1. 159 Posts.
    lightbulb Created with Sketch. 573
    It would probably be good to touch on:
    • To what degree we can attribute these results to Bisantrene (over Clofarabine and Fludarabine).
    • Comparison response rates seen in other anti-cancer P2 drugs that go on to get picked up by BP
    • Can we expect RC220 to have similar efficacy, or perhaps fewer adverse events (lower risk of infection)?
    • Highlight the curious lack of cardiotoxicity despite Clofarabine being highly cardiotoxic!
    • Any exploratory, or circumstantial FTO insights - pretty please
    • Try to include some $$$ numbers - this needs to appeal to all investors, not just the altruistic
    Last edited by SouthernEmpire: 03/11/23
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.48
Change
0.045(3.14%)
Mkt cap ! $248.8M
Open High Low Value Volume
$1.42 $1.48 $1.41 $74.60K 51.49K

Buyers (Bids)

No. Vol. Price($)
1 6944 $1.44
 

Sellers (Offers)

Price($) Vol. No.
$1.48 3096 2
View Market Depth
Last trade - 16.10pm 31/05/2024 (20 minute delay) ?
Last
$1.47
  Change
0.045 ( 1.69 %)
Open High Low Volume
$1.41 $1.48 $1.41 21844
Last updated 15.59pm 31/05/2024 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.